Method for dissociating cell aggregates

US11242503B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11242503-B2
Application numberUS-201716072379-A
CountryUS
Kind codeB2
Filing dateJan 25, 2017
Priority dateJan 26, 2016
Publication dateFeb 8, 2022
Grant dateFeb 8, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for dissociating cell aggregates in an agitated reactor. The method comprises providing a cell culture comprising cell aggregates in the agitated reactor, contacting the cell aggregates with a dissociation reagent, generating a dissociation force in the agitated reactor and exposing the contacted cell aggregates to the generated dissociation force under conditions sufficient to dissociate the contacted cell aggregates. The method may be used in a process for passaging cells and/or generating dissociated differentiated cells from stem and/or progenitor cells.

First claim

Opening claim text (preview).

We claim: 1. A method for dissociating cell aggregates in an agitated reactor, the method comprising: providing a cell culture having a volume of at least about 500 mL comprising cell aggregates in the agitated reactor; contacting the cell aggregates with a dissociation reagent; and applying a dissociation force generated by the agitated reactor to the cell aggregates under conditions sufficient to dissociate the cell aggregates, comprising exposing the cell aggregates to the applied dissociation force for 4 hours or less. 2. The method of claim 1 , wherein the contacting occurs: before or at substantially the same time as the applying of the dissociation force in the agitated reactor. 3. The method of claim 1 , wherein the dissociation force is generated by movement of a stirrer, impeller, paddle, or wheel, by rocking, or by forced fluid flow entering the agitated reactor. 4. The method of claim 1 , wherein the providing step comprises exposing the cell culture to a culture force in the agitated reactor and wherein the dissociation force is about 50% to 500% of the culture force. 5. The method of claim 1 , further comprising: washing the cell culture prior to contacting the cell aggregates with the dissociation reagent; neutralizing and/or diluting the dissociation reagent; and/or washing the dissociated cells. 6. The method of claim 1 , wherein the method is carried out in a closed system. 7. The method of claim 1 , wherein the agitated reactor is a stirred tank reactor, wave-mixed/rocking reactor, up and down agitation reactor, spinner flask, shake flask, shaken bioreactor, paddle mixer, or vertical wheel bioreactor. 8. The method of claim 1 , wherein the cell culture comprises a volume of about 500 mL-2,000 L. 9. The method of claim 1 , wherein the cell culture comprises about 1×10 6 cells/mL to 1×10 15 cells/mL. 10. The method of claim 1 , wherein the dissociated aggregates have a cell viability between about 50% and 100%. 11. The method of claim 1 , wherein the dissociated aggregates comprise: aggregates that are at least 50% smaller than the provided cell aggregates; or substantially single cells. 12. The method of claim 1 , wherein the provided cell aggregates have a diameter of about 150 microns to 800 microns. 13. The method of claim 1 , wherein the cell aggregates substantially comprise: pluripotent stem cells; multipotent stem and/or progenitor cells; and/or somatic cells. 14. The method of claim 1 , wherein the dissociation force generated comprises a Kolmogorov eddy size less than the size of the largest cell aggregate and greater than the diameter of a cell in the cell aggregates at Reynolds number >1000. 15. The method of claim 1 , wherein the contacting occurs after the applying of the dissociation force in the agitated reactor. 16. The method of claim 1 , wherein the providing step comprises exposing the cell culture to a culture force in the agitated reactor and wherein the dissociation force is about 100% of the culture force. 17. The method of claim 1 , wherein the cell culture comprises a volume of between about 1 L to 1,000 L. 18. The method of claim 1 , wherein the dissociated aggregates have a cell viability greater than 80%. 19. The method of claim 1 , wherein the provided cell aggregates have a diameter of about 200 microns to 400 microns. 20. The method of claim 1 , wherein the agitated reactor is a stirred tank reactor. 21. The method of claim 1 , wherein the cell aggregates are exposed to the applied dissociation force for about 10 minutes. 22. A method for passaging cells, the method comprising: providing a cell culture having a volume of at least about 500 mL comprising cell aggregates in a first agitated reactor; contacting the cell aggregates with a dissociation reagent; applying a dissociation force generated by the agitated reactor to the cell aggregates under conditions sufficient to dissociate the cell aggregates, comprising exposing the cell aggregates to the applied dissociation force for 4 hours or less; and culturing at least a portion of the dissociated cell aggregates, thereby passaging the cells. 23. The method of claim 22 , wherein the portion of the dissociated aggregates is cultured in the first agitated reactor. 24. The method of claim 22 , wherein the portion of the dissociated aggregates is cultured in a second agitated reactor. 25. The method of claim 24 , wherein the second agitated reactor is a different type of agitated reactor and/or is a different size than the first agitated reactor. 26. The method of claim 24 , wherein the second agitated reactor is larger than the first agitated reactor. 27. A method for generating dissociated differentiated cells from a stem or progenitor cell population within an agitated reactor, the method comprising: providing a cell culture having a volume of at least about 500 mL comprising a population of stem and/or progenitor cells in the agitated reactor; differentiating the stem and/or progenitor cells into differentiated cell aggregates within the agitated reactor under conditions suitable for differentiation; contacting the differentiated cell aggregates with a dissociation reagent; and applying a dissociation force generated by the agitated reactor to the cell aggregates under conditions sufficient to dissociate the differentiated cell aggregates, comprising exposing the cell aggregates to the applied dissociation force for 4 hours or less.

Assignees

Inventors

Classifications

  • C12M45/02Primary

    by mechanical forces; Stirring; Trituration; Comminuting (crushing, pulverizing, disintegrating in general B02C) · CPC title

  • Culture process characterised by the use of hydrostatic pressure, flow or shear forces · CPC title

  • 3D culture · CPC title

  • Stirrer or mobile mixing elements · CPC title

  • by enzymatic treatment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11242503B2 cover?
A method for dissociating cell aggregates in an agitated reactor. The method comprises providing a cell culture comprising cell aggregates in the agitated reactor, contacting the cell aggregates with a dissociation reagent, generating a dissociation force in the agitated reactor and exposing the contacted cell aggregates to the generated dissociation force under conditions sufficient to dissoci…
Who is the assignee on this patent?
Centre For Commercialization Of Regenerative Medicine, Governing Council Univ Toronto
What technology area does this patent fall under?
Primary CPC classification C12M45/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).